1. HIV test-and-treat policy improves clinical outcomes in Zambian adults from Southern Province: a multicenter retrospective cohort study
- Author
-
Benson M. Hamooya, Simon Mutembo, Brian Muyunda, Keith Mweebo, Nzali Kancheya, Lyapa Sikazwe, Morgan Sakala, Johanzi Mvula, Salazeh Kunda, Shem Kabesha, Chilala Cheelo, Isaac Fwemba, Clive Banda, and Sepiso K. Masenga
- Subjects
retention ,HIV ,testing ,antiretroviral therapy ,Zambia ,clinical outcomes ,Public aspects of medicine ,RA1-1270 - Abstract
BackgroundGlobally, most countries have implemented a test-and-treat policy to reduce morbidity and mortality associated with HIV infection. However, the impact of this strategy has not been critically appraised in many settings, including Zambia. We evaluated the retention and clinical outcomes of adults enrolled in antiretroviral therapy (ART) and assessed the impact of the test-and-treat policy.MethodsWe conducted a retrospective cohort study among 6,640 individuals who initiated ART between January 1, 2014 and July 31, 2016 [before test-and-treat cohort (BTT), n = 2,991] and between August 1, 2016 and October 1, 2020 [after test-and-treat cohort (ATT), n = 3,649] in 12 districts of the Southern province. To assess factors associated with retention, we used logistic regression (xtlogit model).ResultsThe median age [interquartile range (IQR)] was 34.8 years (28.0, 42.1), and 60.2% (n = 3,995) were women. The overall retention was 83.4% [95% confidence interval (CI) 82.6, 84.4], and it was significantly higher among the ATT cohort, 90.6 vs. 74.8%, p
- Published
- 2023
- Full Text
- View/download PDF